6. After coupling was completed, the reaction solution was drawn off and the resin sequentially washed with DMF (10 x 10x resin volume), DMF:DMSO (1:1, 3 x 5x resin volume) and DCM:methanol (1:1, 2 x 5x resin volume). The resin was thoroughly dried under vacuum.
7. Hydrazine (2% in DMF, 10x resin volume) was added and shaken for 10 min (to effect removal of Dde from Lys). This procedure was repeated two more times with fresh hydrazine -DMF solution.
8. After washing the resin with DMF (10 x 10x resin volume), an isopycnic resin solution (a solution of DMF:DCM which gives homogeneous distribution of resin as a slurry; see Note 1 below) was prepared. Equal volumes (calculated resin amounts ~5 mg; see Note 2 below) of this slurry were distributed in the PALL 96-well filter plates. The solvent was removed by centrifugation (2000 g) with a collection 96-well plate at the bottom. 9. PyBOP (5n mol, 0.3 M), HOBt (5n mol, 0.3 M) and NMM (25n mol) in DMF were combined, and an aliquot of the solution (75 µL) was added to each well using a multichannel pipette. Aliquots (50 µL) of organic acids (10 nmol, 0.6 M in DMF) from a pre-prepared 96-well stock plate (containing 92 different acids) were added to each well. The plates were shaken overnight (ca. 12 h), attached to an orbital shaker to complete the coupling reaction. 11. Into each well was added TFA cleavage solution (100 µL; TFA/triisopropyl silane (TIS)/thioanisole/water (94:2:2:2)), and allowed to incubate for 2 h.
12. After completion of the cleavage, the compounds in TFA solution were collected into Whatman UNIPLATE 96-well, 750 µL multichem round bottom plates by centrifugation (3000 g). Fresh pure TFA (2 x 25 µL) was placed in each well and again collected into the same plate as described above. Cold diethyl ether (500 µL) was added to each well to precipitate out the modified peptides, and the plate immediately centrifuged (3000 g) to collect the precipitates. The solvent was removed, and fresh cold ether (500 µL) was added to wash the precipitate, followed again by centrifugation. This cold ether washing procedure was repeated for a third round to completely remove any remaining TFA.
13. Modified peptides in each well were dissolved in deionized water (400 µL), and the plate stored at -20 °C until needed for screening.
Synthesis of Library II (N-Biotin-(Ahx) 2 -Tyr-Lys-Gln-Thr-((N-e-COR)Dap)-Val)
All steps were performed as per the procedure for Library I synthesis, with the follow-
Step 3; and 2) 186 instead of 92 organic acids were used in Step 9. 5. The solution was removed with a multichannel pipettor and the plate washed with TBST buffer (3 x 100 µL).
ELISA Screening
6. Anti-GST primary antibody (100 µL of 1:1000 dilution) in start block blocking buffer was added to each well and incubated for 1 h at room temperature.
7. The solution was removed with a multichannel pipettor and the plate washed with TBST buffer (3 x 100 µL).
8. Alkaline phosphatase conjugated secondary antibody (100 µL of 1:5000 dilution) in start block blocking buffer was added to each well and incubated for 0.5 h at room temperature.
9. The wells were washed thoroughly (5 x with TBST buffer ((4 x 100 µL) and a final wash of 1 x 200 µL)).
10. p-Nitrophenyl phosphate, disodium salt (PNPP) substrate solution (100 µL) was added to each well, and the absorbance values ( λ = 405 nm) were measured after 15 min using a Tecan Spectrafluor platereader.
Individual (Preparative Scale) Synthesis of Selected Modified Peptides
1. Each of the selected compounds ( Figure 2 and HOBt (5n mol, 0.3 M) and NMM (25n mol) in DMF and a llowed to shake overnight (ca. 12 h).
3. The crude acylated peptide was isolated by adding TFA cleavage solution (4 mL) TFA/triisopropyl silane (TIS)/thioanisole/water (94:2:2:2)) and incubating for 2 h, followed by precipitation with cold ether, redissolving in water and lyopilization.
Purification and Analysis of Organic Modified Peptides
A small portion of the lyophilized powder was used for preliminary mass (by MALDI -TOF and ESI-MS) and purity (analytical RP-HPLC) characterization. For the latter, ca.
1.5 mg of the powder was dissolved in H 2 O (0.5 mL). In determining an appropriate ratio for the methanol: H 2 O (0.1% TFA) solvent system used for HPLC separation (C18 RP-HPLC Phenomenex column), small injections (20 µL) were made at different ratios. After a satisfactory solvent system was found, the purification was performed at a preparative scale (50 mg/mL of crude peptide). The major single peak fractions of each run was collected and combined, frozen and lyophilized to a powdered solid. The purified material was subjected to mass spectral analysis, and an analytical scale RP-HPLC was performed again to confirm a single peak. If the analysis displayed more than one peak, a repurification was performed until a single peak was observed.
Isothermal Titration Calorimetry (ITC)
Preparation of isolated (non-fusion form) PDZ3 and standard ITC binding experiments were conducted with minimal deviations from the methods as previously described (Biochemistry 2007, 46, 6340-52) using a VP-ITC microcalorimeter (Microcal).
Briefly, PDZ3 subcloned from PSD-95 protein (residues 302-402) was expressed in E.
coli BLR-Gold as a glutathione -S-transferase (GST) fusion protein, then isolated after trypsin cleavage from the GST and chromatographic purification steps. After PDZ3
was extensively dialyzed (24 h) in the chosen buffer (20 mM MES, 10 mM NaCl, pH 6.00), the dialysis buffer was saved and used to dissolve the ligands to be titrated . Thermodynamic parameters were determined by non-linear least squares fitting using a One Set of Binding Sites model.
HSQC Chemical Shift Perturbation
Original resonance assignments and structure determination of PSD-95 PDZ3 by Struct. Biol. 1996, 3, 340-345) . The normalized differential chemical shift obtained for compound 1 compared to peptide YKQTKV for each residues were plotted in Figure S1 . A normalized amide chemical shift index value of 1 or larger was considered a substantial change. Figure S1 . Normalized differential chemical shift change for compound 1 compared to YKQTKV. The red asterisk denotes proline residues (which lack an amide proton and cannot be tracked), while residues whose resonance disappeared during titration are represented by blank columns in the chart. 
